Thomson Reuters INNOVATION AWARDS 2011 – INDIA

THE LaLiT NEW DELHI, BARAKHAMBA AVENUE, CONNAUGHT PLACE

 

Download Thomson Reuters Top 100 Global Innovators Report

Innovation Awards 2010

Intelligent Information For Life

The Knowledge Effect
The right information in the right hands leads to amazing things

 

IN THE NEWS

India generics companies lead pharmaceutical innovation in Asia Pacific
Multi-national pharmaceutical companies are likely to face increased competition for new molecular entities from India-based generic companies.

India ranked 6th globally in materials science research
India occupies the sixth position in terms of research output in material sciences, and is one of the leading countries in the Asia Pacific region

Outsell Releases Thomson Innovation Product Review
"Thomson Innovation is a superb patent search service with international coverage that is both broad and deep, but it is much more than a patent search service... define Thomson Innovation as an information management solution rather than a simple search engine."

India Innovation Awards 2010

A key indicator of innovation is patenting activity. The importance of intellectual property as a major source for economic and technological development in India is demonstrated by the increasing creativity and impact of Indian research and technology throughout the world as measured by patenting activity.

The last five years have seen a substantial increase in Indian patent applications from 24,505 applications in 2006 to over 34,000 applications in 2010 at an average CAGR (Compound Annual Growth Rate) of 8.8 percent.

Since 2007, Thomson Reuters has been presenting the Thomson Reuters Innovation Awards to recognize innovation and entrepreneurship in India. The award recognizes the most innovative academic institutions and commercial enterprises headquartered in India for their spirit of innovation in R&D as it relates to all aspects of patent publications in India.

Four awards are presented across four different industrial sectors: Pharma Corporate, Pharma Academic & Government, Hi-Tech Corporate and Hi-Tech Academic & Government.

Criteria for award include the number of patents, the success of innovation and the influence of innovation as measured by patent citations. Previous award winners are excluded from consideration for the award although still included in the analysis.

The award winners were announced in Delhi, India on November 17, 2011.

Agenda

Program Agenda

Time Activities Speaker
12:00 PM Guest Registration Starts  
12:30–12:35 PM
(05 mins)		 Welcome Address Dr. Y S Rajan, Dr. Vikram Sarabhai
Distinguished Professor
Indian Space Research Organization
12:35–12:40 PM
(05 mins)		 Thomson Reuters business overview Mr. Christopher Kibarian
President, IP & Science
Thomson Reuters
12:40–12:50 PM
(10 mins)		 Thomson Reuters Innovation Awards Methodology Mr. Mark Garlinghouse
SVP & Managing Director, Asia Pacific
Thomson Reuters
12:50–01:05 PM
(15 mins)		 Presentation Ceremony:
Thomson Reuters Innovation Awards 2011–India		 Dr. Ashwani Kumar, Hon'ble Minister of State for Ministry of Science & Technology, Ministry of Earth Sciences & Ministry of Planning
01:05–01:20 PM
(5 mins)		 Guest-of-Honor
Keynote Address		 Dr. Ashwani Kumar, Hon'ble Minister of State for Ministry of Science & Technology, Ministry of Earth Sciences & Ministry of Planning
01:20–01:25 PM
(05 mins)		 Closing Remarks Dr. Woei Fuh Wong
Managing Director — South Asia & South-east Asia
Thomson Reuters
01:25 PM Group Photography of Presenters and Awardees on Stage  
01:30 PM Lunch  
Awardees

Hi-Tech Corporate

Tata Steel Limited

Established over 100 years ago, Tata Steel Limited is among the top ten global steel companies and one of the world's most geographically-diversified steel producers, with a commercial presence in over 50 countries. Headquartered in Jamshedpur, it is the largest private-sector steel company in India measured by domestic production and also India's second-largest and second-most profitable private-sector company.

Tata Steel’s decisive foray into global territory by new expansions and initiation of new projects are a few highlights in their expanding and more penetrative roles in the larger perspective. The acquisition of NatSteel in 2004 was Tata Steel’s first overseas acquisition and the series of joint ventures and mergers that followed found a peak with the acquisition of Corus in April 2007.

Research & Development (R&D) activity within the Tata Steel Group takes place in 5 major centres namely, the IJmuiden Technology Centre (the Netherlands), the Swinden Technology Centre (United Kingdom), the Teesside Technology Centre (United Kingdom), the Automotive Engineering Group (United Kingdom) and the Jamshedpur R&D Centre (India). These centres hold just over 1,000 employees globally. A clear focus on development of cutting edge technology has enabled Tata Steel to become one of the lowest cost steel producers worldwide. Current activities in this area include research on agglomerates chemistry, blast furnace burden distribution, integrated through-process modelling, reduced zinc consumption during tube galvanising, and many others. Tata Steel’s R&D centres also conduct many programmes to improve the life cycle and sustainability of its products. These include projects to reduce energy consumption, CO2 and other emissions.

The initiatives taken over the years have helped Tata Steel increase its total IP portfolio (filed and granted patents and copyrights) from 32 in FY 2000 to more than 493 till date. Out of these some patents have been granted, and the remaining have been filed and are at different stages in the process of being granted.

Hi-Tech Academic & Government

Defence Research and Development Organisation(DRDO)

Headquartered in New Delhi, Defence Research and Development Organisation (DRDO) works under the Department of Defence Research and Development of the Government of India Ministry of Defence. DRDO’s work is dedicated to enhance self-reliance in Defence Systems and undertakes design & development leading to production of world class weapon systems and equipment to meet the needs and requirements of the three armed services.

Formed in 1958 by the merger of Technical Development Establishment and the Directorate of Technical Development and Production with the Defence Science Organisation, DRDO has a network of over 50 laboratories deeply engaged in developing defence technologies covering various fields, like aeronautics, armaments, electronics, combat vehicles engineering systems, instrumentation, missiles, advanced computing and simulation, special materials, naval systems, life sciences, training, information systems and agriculture. Backed by over 5000 scientists and about 25,000 other scientific, technical and supporting personnel. DRDO has made significant achievements in the development of missiles, armaments, light combat aircrafts, radars, electronic warfare systems etc.

While striving to meet the cutting edge weapons technology requirements, DRDO also provides ample spinoff benefits to the society at large thereby contributing to the nation building.

PharmaCorporate

Dr. Reddy's Laboratories Limited

Established in 1984, Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products. Dr. Reddy’s offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars, differentiated formulations and News Chemical Entities (NCEs).

The company also conducts research in the areas of cancer, diabetes, cardiovascular, inflammation, and bacterial infection. In addition, it involves in the contract manufacture generic prescription and over-the-counter products for branded and generic companies in the United States. The company primarily focuses on therapeutic categories of cardiovascular, diabetes management, gastro-intestinal, and pain management. It markets its products in India, the United States, Europe, and the Russian Federation.

Dr. Reddy’s Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India.

PharmaAcademic & Government

National Institute of Pharmaceutical Education and Research (NIPER)

National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an 'Institute of National Importance'. It is an autonomous body set up under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.

The Institute was conceived to provide leadership in pharmaceutical sciences and related areas not only within the country, but also to the countries in South East Asia, South Asia and Africa. NIPER is a member of Association of Indian Universities and Association of Commonwealth Universities.

Methodology

KEY ANALYSIS TECHNIQUES

Four metrics were used to assess the level of innovation of candidate companies, which are mentioned below:

SIZE OF PORTFOLIO
The volume of new inventions originating in India, published in 2009-2010 was assessed for Indian organizations. A new invention is defined as the first publication in a patent document of a new technology, drug, business process, etc. In DWPI these are called “Basic” patents. DWPI provides a record of patents published by 47 patent issuing authorities worldwide to enable a comprehensive picture of activity to be produced. Subsequent filings for the same invention are recorded as “Equivalents” in DWPI and collated with the Basic in “patent families” to summarize the patents relating to that invention. For this analysis, Equivalents were not counted so we have a measure of how many new unique inventions the entities are responsible for.

The DWPI database was searched for recent inventions originating from India (India as priority country) and published from 2009-2010. The records were ranked by assignee to identify the top organizations in the four award categories by size of portfolio.

SUCCESS RATE
Patenting an invention through one or more patent offices is expensive. Not all patent applications pass through the patent examination process at the patent offices to become granted. So the ratio of granted patents to all new inventions published during 2009-2010 is a measure of success.

A search of candidate organizations was made to determine the ratio of granted patents to all new inventions and candidates ranked accordingly.

EXTENT OF GLOBALIZATION
Protecting an invention in major world markets is an indication that an organization places a significant value on those pieces of their intellectual property.

The number of new invention patents that have foreign (non-India patents) in their patent families was calculated to create a ratio to show which companies place a high value on their intellectual property (IP) and organizations ranked accordingly.

INFLUENCE OF INNOVATION
The importance of an organization’s innovation can also be measured by considering the impact of inventions ‘down the line’. This can be determined by looking at how often inventions are subsequently cited by other companies in their development of a technology area. The Derwent Patents Citation Index™ database was therefore used to count citations to the organization’s new inventions over the most recent ten years excluding self- citations.

AGGREGATE RANKINGS

The final list was determined using these key performance indices in combination to give a multi-faceted perspective and enable us to identify the Top Indian Academic and Corporate Innovators in the Pharma sector and Hi-tech sectors.

ABOUT THE ANALYSES

Analyses performed in this report used data from Thomson Innovation®, the premier intellectual property research and analysis solution from Thomson Reuters. Thomson Innovation is a single, integrated solution that combines intellectual property, scientific literature, business data and news with analytic, collaboration and alerting tools in a robust platform. Data from Derwent World Patents Index® and Derwent Patent Citation Index® was also used.

Downloads & Media Coverage

In the News

To View the Photos Click Here